MedicalResearch.com Interview with:
Associate Professor Dianna Magliano BAppSci(Hon) MPH PhD
Head, Diabetes and Population Health
Baker IDI Heart and Diabetes Institute
MedicalResearch.com: What is the background for this study? What are the main findings?
Dr. Magliano: This work shows that Australians with type 1 diabetes had an estimated life loss of 11.6 years for men and 12.5 years for women compared with the general population. We saw no evidence of improvement in this over recent years. For those who are older with type 1, cardiovascular disease contributed substantially to the years of life lost in type 1 diabetes. Death before 60 years and mortality from endocrine and metabolic disease were also important contributors to the years of life lost in type 1 diabetes.
MedicalResearch.com: What should clinicians and patients take away from your report?
Dr. Magliano: Despite the advances in treatment of type 1 diabetes, this disease is still associated with substantial mortality.
MedicalResearch.com: What recommendations do you have for future research as a result of this study?
Dr. Magliano: For improvements in life expectancy, greater attention must therefore be paid to both the acute metabolic and chronic cardiovascular complications of type 1 diabetes.
MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community.
Diabetologia. 2016 Jan 21. [Epub ahead of print]
Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study.
Huo L1,2, Harding JL3,4, Peeters A3,4, Shaw JE3,4, Magliano DJ3,4.
Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.
Associate Professor Dianna Magliano (2016). Type 1 Diabetes Still Associated With At Least A Decade of Reduced Life Expectancy MedicalResearch.com